LIGHT AI
SYMBOL(S):
CBOE CA: ALGO | FSE: OHCN
- Common Issued & Outstanding Shares: 116,230,671 (as of 02/1/2025)
- Stock Options: 7,113,945 (as of 02/01/2025)
- Light.ai
Light AI is at the forefront of a healthcare revolution, harnessing assistive artificial intelligence to transform disease diagnostics.
The company’s technology streamlines and enhances diagnostic accuracy, starting with infectious diseases like strep throat, empowering healthcare providers to make faster, more confident decisions about antibiotic use—a critical step in combating antibiotic resistance and improving patient outcomes.
The Technology: Light AI has developed a mobile phone-based tool that enables doctors to perform telemedicine evaluations using an AI-based scanning technology that identifies infections for precise treatment.
Why Invest Now?
- Early investors in AI-driven healthcare companies have seen massive ROI, as AI adoption in medicine is still in its early stages.
- First-mover advantage: Light AI is among the first to deploy AI-driven rapid diagnostics for infectious diseases, creating a barrier to entry for competitors.
- AI in diagnostics is projected to grow at a double-digit CAGR, making now the perfect time to invest in an early-stage disruptor like Light AI.
Invest in the Future of AI-Driven Healthcare with Light AI
AI is set to redefine healthcare, unlocking a $140+ billion market opportunity by transforming diagnostics, treatment, and efficiency. With antimicrobial resistance skyrocketing and misdiagnoses costing hundreds of thousands of lives, AI-driven solutions like Light AI offer precision, speed, and scalability at an unprecedented level. The future of medicine depends on data-driven decision-making, and early investors in AI-powered healthcare will be positioned at the forefront of one of the most profitable and impactful revolutions in modern history.
Company Beliefs
- Technology must deliver value
- Equity drives progress
- Purposeful collaboration amplifies impact
- Compassion fuels purpose
- Change propels us forward
The Urgent Need for AI-Driven Diagnostics
Every year, over 600 million people worldwide are infected with diseases like Strep A, leading to more than 500,000 deaths. The situation is becoming even more critical with the rise of antimicrobial resistance (AMR)—a growing crisis that could drive healthcare costs up by $1 trillion by 2050.*
One of the biggest challenges? Limited access to rapid, accurate testing. Without it, precautionary antibiotics are overprescribed, accelerating resistance and making treatments less effective over time.
At Light AI, they are changing this reality. Their AI-powered diagnostic technology delivers fast, reliable testing at the point of care, giving healthcare professionals the tools they need to determine when antibiotics are truly necessary—helping to reduce overuse, protect vital resources, and save lives.
By investing in Light AI, you’re not just supporting a breakthrough in healthcare—you’re backing a transformative solution that is poised to reshape diagnostics, reduce global healthcare costs, and protect the future of medicine.
*Source: World Bank, Nov. 2023
Investor Presentation
More Than Technology — It’s About Trust
This isn’t just about delivering a tool. It’s about empowering providers with the confidence to act, and ensuring that no community is left behind in the fight against preventable diseases. At Light AI, we believe everyone deserves access to timely, accurate care.- Peter Whitehead, Founder
Partners Have Confidence in Light AI
Light AI is proud to work with partners who share their vision to tackle global health challenges and improve lives worldwide.
Leadership
Officers
Peter Whitehead
CEO
George Reznik
CFO and Corporate Secretary
Thomas Scarnecchia
COO
Advisors
Anthony Schaller
David Talan
Yu Zhao
Raymond Ng
David Bell
Board
Steven Semmelmayer
Chair
Mark Attanasio
Hugh Cleland
Emmanuel Blin
Looking for your next big investment opportunity?
Get Stock Alerts Instantly! Join EMC’s Exclusive WhatsApp and Telegram Groups For Savvy Investors
- There’s no obligation, and EMC deliver the best Small Cap Stock Alerts straight to your phone and you inbox at no cost!
- Stay ahead of the market with expert insights, fast-moving trends, and high-potential stock picks. Maximize your portfolio with the most reliable and timely alerts.
- Don’t miss out—subscribe and get an edge on your small cap investments!
Recent News
- Healthcare Technology Company Light AI Announces Advisory Board to Augment Board of Directors – February 6, 2025
- Light AI announces marketing and investor awareness campaign – January 29, 2025
- Light AI Appoints George Reznik CFO and Corporate Secretary – January 27, 2025
- Light AI announces closing of over-allotment option and trading on cboe Canada – January 8, 2025
- Cboe Canada Announces Public Listing of Diagnostic Software Company Light AI – January 8, 2025
Must Read OTC Markets/SEC policy on stock promotion and investor protection
Disclaimer
EMC has been paid $150,000 by Light AI Inc. | Please read our full disclaimer
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact